RE:Roche CD47 antibody start-up gives up-lays off all employeesRepost from January 13, 2023
hanks to Dude1234 on Stocktwits for providing the heads-up
https://endpts.com/scoop-roche-backed-startup-gives-up-on-cd47-as-ceo-most-employees-leave/
Along with Roche's CD47 acquisition, Roche's anti-TIGIT drug tiragolumab also has not done very well - placing Roche's continued hope on their immune checkpoint inhibitor Tecentriq.